Rigel Pharmaceuticals Inc Net Income per Employee (RIGL), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Rigel Pharmaceuticals Inc  (NASDAQ: RIGL)
 

Rigel Pharmaceuticals Inc Net Income per Employee

RIGL's Quarterly Results, Trends, Rankings, Statistics
Rigel Pharmaceuticals Inc's Income per employee fell in the third quarter 2026 on a trailing twelve month basis to $ 1,765,483, but the productivity of Rigel Pharmaceuticals Inc's 174 employees remained above the company average.
The Healthcare sector has seen employees of 11 other companies achieving higher income per employee. While Rigel Pharmaceuticals Inc's total ranking has deteriorated compared to the previous quarter from 97 to 100.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RIGL Net Income per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Net Income Change -52.74 % -71 % -24.39 % 1769.22 % 124.62 %
Net Income per Employee (TTM) $ 1,765,483 1,850,052 2,093,287 2,109,333 651,149
RIGL's Total Ranking # 100 # 97 # 61 # 218 #
Seq. Net Income Change -23.74 % 99.79 % -96.77 % 860.81 % -53.2 %

RIGL Company Profile >> Back to RIGL Efficiency Comparisons >> Compare RIGL Net Income per Employee to its Competitors

RIGL Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 12
Healthcare Sector # 12
Overall Market # 100

Net Income per Employee Statistics
High Average Low
$ 2,109,333 $ -174,108 $ -581,839
(Dec 31 2025)   (Mar 31 2013)







Companies with similar Income per Employee for 12 month ending Sep 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2026Number of Employees Sep 30 2026
Aurinia Pharmaceuticals Inc   2,455,203.13 $ 314.266  Million 128 
Rallybio Corporation  1,915,000.00 $ 26.810  Million 14 
Exelixis Inc   1,454,396.69 $ 1,668.193  Million 1,147 
Zevra Therapeutics Inc   1,273,049.18 $ 77.656  Million 61 
Ligand Pharmaceuticals Incorporated  1,094,936.17 $ 51.462  Million 47 
Alnylam Pharmaceuticals Inc   1,089,695.60 $ 2,724.239  Million 2,500 
Nurix Therapeutics Inc   930,211.36 $ 294.877  Million 317 


Date modified: 2026-11-08T10:01:20+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.